Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial.

Abbas Ali SangouniZahra OrangHassan Mozaffari-Khosravi

Published in: BMC nutrition (2021)

Omega-3 supplementation (2000 mg/d) for 12 weeks has no effect on cardiometabolic risk. It seems, higher doses of omega-3 can improve cordiometabolic risk. The trial was registered at Iranian Registry of Clinical Trials IRCT2016102530489N1.

Keyphrases

clinical trial
study protocol
phase iii
randomized controlled trial
wound healing
preterm birth
double blind